Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

514 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fulvestrant ('Faslodex') in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme.
Mlineritsch B, Psenak O, Mayer P, Moik M, Namberger K, Hauser-Kronberger C, Greil R. Mlineritsch B, et al. Breast Cancer Res Treat. 2007 Nov;106(1):105-12. doi: 10.1007/s10549-006-9482-7. Epub 2007 Feb 13. Breast Cancer Res Treat. 2007. PMID: 17295045 Clinical Trial.
Is Chemoendocrine Treatment without Alternative?
Greil R. Greil R. Breast Care (Basel). 2008;3(4):231-235. doi: 10.1159/000149558. Epub 2008 Aug 22. Breast Care (Basel). 2008. PMID: 21076602 Free PMC article. No abstract available.
[Successful cancer therapy: chance and challenges].
Greil R, Hiddemann W. Greil R, et al. Dtsch Med Wochenschr. 2013 Oct;138(41):2083. doi: 10.1055/s-0033-1349623. Epub 2013 Oct 1. Dtsch Med Wochenschr. 2013. PMID: 24085360 German. No abstract available.
Antiangiogenic therapy in breast cancer.
Gampenrieder SP, Westphal T, Greil R. Gampenrieder SP, et al. Memo. 2017;10(4):194-201. doi: 10.1007/s12254-017-0362-0. Epub 2017 Nov 6. Memo. 2017. PMID: 29250196 Free PMC article. Review.
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).
Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R; Austrian Breast, Colorectal Cancer Study Group (ABCSG). Mlineritsch B, et al. Breast Cancer Res Treat. 2008 Nov;112(1):203-13. doi: 10.1007/s10549-007-9843-x. Epub 2007 Dec 22. Breast Cancer Res Treat. 2008. PMID: 18158620 Clinical Trial.
Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.
Hilbe W, Kühr T, Apfelbeck U, Fridrik M, Seewann H, Stöger M, Linkesch W, Pont J, Baldinger C, Hartner E, Bernhart M, Geissler D, Krieger O, Lang A, Lin W, Ludwig H, Duba C, Greil R, Gast G, Thaler J. Hilbe W, et al. Leuk Lymphoma. 2001 Nov-Dec;42(6):1283-8. doi: 10.3109/10428190109097753. Leuk Lymphoma. 2001. PMID: 11911409 Clinical Trial.
514 results
Jump to page
Feedback